REFERENCES
- Gilman J T. Carbamazepine dosing for pediatric seizure disorders: The highs and the lows. DICP 1991; 25: 1109–1112
- Stremski E S, Brady W B, Prasad K, Hennes H A. Pediatric carbamazepine intoxication. Ann Emerg Med 1995; 25: 624–630
- Bridge T A, Norton R L, Robertson W O. Pediatric carbamazepine overdoses. Pediatr Emerg Care 1994; 10: 260–263
- Leslie P J, Heyworth R, Prescott L F. Cardiac complications of carbamazepine intoxication: Treatment by haemoperfusion. Brit Med J Clin Res Ed 1983; 286: 1018
- Chavers B M, Kjellstrand C M, Wiegand C, Ebben J, Mauer S M. Techniques for use of charcoal hemoperfusion in infants: Experience in two patients. Kidney Int 1980; 18: 386–389
- Barth R H, DeVincenzo N. Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy. Kidney Int 1996; 50: 929–936
- Bunchman T E, Valentini R P, Gardner J J, Mottes T, Kudelka T, Maxvold N J. Treatment of vancomycin over- dose using high efficiency dialysis membranes. Pediatr Nephrol 1999; 13: 773–774
- Panzarino V M, Feldstein T J, Kashtan C E. Charcoal hemoperfusion in a child with vancomycin overdose and chronic renal failure. Pediatr Nephrol 1998; 12: 63–64
- Donckerwolcke R, Bunchman T E. Hemodialysis — Modalities and management in infants and small children. Pediatr Nephrol 1994; 8: 103–106
- Welage L S, Mason N A, Hoffman E J, et al. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics. J Am Soc Nephrol 1995; 6: 1284–1290